Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiated Thyroid Carcinoma (DTC)”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Very early researchLooking for participantsNCT06898437
What this trial is testing

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04952493
What this trial is testing

Anlotinib or Penpulimab in Combination With RAI for DTC

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193186
What this trial is testing

Anlotinib and Benmelstobart in DTC

Who this might be right for
Thyroid Cancer
Fudan University 23
Not applicableLooking for participantsNCT06980103
What this trial is testing

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Who this might be right for
Thyroid Cancer
Georgetown University 408
Testing effectiveness (Phase 2)Looking for participantsNCT06359847
What this trial is testing

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Carcinoma
Beijing Scitech-Mq Pharmaceuticals Limited 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04940052
What this trial is testing

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer (DTC)
Novartis Pharmaceuticals 153
Testing effectiveness (Phase 2)Study completedNCT02973997
What this trial is testing

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Who this might be right for
Columnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more
Academic and Community Cancer Research United 57
Not applicableLooking for participantsNCT05024929
What this trial is testing

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Who this might be right for
Papillary Thyroid CancerPediatric CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia 32
Testing effectiveness (Phase 2)Study completedNCT01788982
What this trial is testing

Nintedanib(BIBF1120) in Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)Differentiated Thyroid Cancer (DTC)
European Organisation for Research and Treatment of Cancer - EORTC 100
Not applicableLooking for participantsNCT05510934
What this trial is testing

Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.

Who this might be right for
Low Risk Differentiated Thyroid Cancer
Nova Scotia Health Authority 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093
What this trial is testing

Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib

Who this might be right for
DTC - Differentiated Thyroid Cancer
Yansong Lin 20
Not applicableLooking for participantsNCT06405217
What this trial is testing

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Who this might be right for
DTC - Differentiated Thyroid CancerThyroid Stimulating; Hormone, CRadiotherapy; Complications
Nanjing First Hospital, Nanjing Medical University 30
Not applicableStudy completedNCT03239769
What this trial is testing

Compare the Aesthetic Effect of Different Thyroidectomies

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)
Peking University Cancer Hospital & Institute 120
Testing effectiveness (Phase 2)Study completedNCT02432274
What this trial is testing

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Who this might be right for
TumorsSolid Malignant TumorsOsteosarcoma+1 more
Eisai Limited 117
Not applicableStudy completedNCT07229859
What this trial is testing

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

Who this might be right for
Differentiated Thyroid Cancer (DTC)Robotic Assistance
Ruijin Hospital 332
Post-approval studies (Phase 4)Ended earlyNCT03065218
What this trial is testing

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Who this might be right for
Thyroid Cancer
Medstar Health Research Institute 4
Large-scale testing (Phase 3)Study completedNCT02966093
What this trial is testing

A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China

Who this might be right for
Differentiated Thyroid Cancer (DTC)
Eisai Co., Ltd. 151
Large-scale testing (Phase 3)Looking for participantsNCT06558981
What this trial is testing

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Who this might be right for
Thyroid Cancer
Fudan University 124
Large-scale testing (Phase 3)Not Yet RecruitingNCT07239674
What this trial is testing

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

Who this might be right for
Intermediate-to-High Risk Differentiated Thyroid Cancer
West China Hospital 646
Not applicableActive Not RecruitingNCT02185560
What this trial is testing

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib

Who this might be right for
Thyroid Carcinoma
Bayer 453
Load More Results